- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 513/22 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or in which the condensed system contains four or more hetero rings
Patent holdings for IPC class C07D 513/22
Total number of patents in this class: 237
10-year publication summary
|
5
|
14
|
12
|
5
|
10
|
12
|
27
|
26
|
38
|
16
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1581 |
16 |
| Merck Patent GmbH | 5909 |
13 |
| Janssen Pharmaceutica N.V. | 3839 |
8 |
| Gilead Sciences, Inc. | 1879 |
8 |
| Hangzhou DAC Biotech Co., Ltd | 99 |
8 |
| Sumitomo Chemical Company, Limited | 8808 |
6 |
| Revolution Medicines, Inc. | 153 |
5 |
| Bristol-myers Squibb Company | 5080 |
4 |
| F. Hoffmann-La Roche AG | 7958 |
4 |
| Hoffmann-La Roche Inc. | 3060 |
4 |
| Massachusetts Institute of Technology | 9795 |
4 |
| Raynergy Tek Inc. | 107 |
4 |
| Novartis AG | 11238 |
3 |
| FUJIFILM Corporation | 27102 |
3 |
| Osaka University | 3143 |
3 |
| Rohm and Haas Electronic Materials Korea Ltd. | 546 |
3 |
| Xenon Pharmaceuticals Inc. | 190 |
3 |
| Fundacion Del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III (f.s.p. Cnio) | 51 |
3 |
| Janssen Sciences Ireland Unlimited Company | 431 |
3 |
| University of Sharjah | 36 |
3 |
| Other owners | 129 |